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In the discussion biological explanations for the results are given. These interpretations are mainly based on speculations. The simple interpretation that the QoL measure captures the same symptoms like CHD is not given. The authors argue that QoL measures can be used for a comprehensive view on patients. This would require having a comprehensive view also on the strengths. In the overall results emotional functioning does not seem to be affected by the presence of CHD (which is amazing according to the fact that depression is an established risk factor). A deeper elaboration of the innovative potentials of the findings would help readers to understand the message precisely. The finding that QoL is impaired in patients with CHD is not very innovative without adding some specific findings from this study. This might also require to state that QoL is partially not as much affected as previously thought.
Minor comments:
The presentation of the results of table 2 in the text is highly selective. Non-significant results have not been discussed.
The "random" selection of participants (see discussion) has not been described in detail in the method section.
The presentation of an OR of 1 in Table 2 is not necessary.
The references require editing.
Captions of tables should be reduced to important information.
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THE STUDY -Authors said something on the eligible participant without any information on eligibility criteria.
-There are some concerns on representativeness of the sample, especially authors did not give any information on the exposure distribution in the non-participant. If non-participant was related to CVD, then sample may not be representative.
-One main previous study with same research question was missed. It caused that authors claim that their study is the first of its type.
-There are some items which are not reported in the manuscript (e.g., sources of potential biases, the reasons for non-participation, methods for handling missing values, no information on interaction analysis, no discussion on generalisability of the results and etc. RESULTS & CONCLUSIONS -As I said, there are some concerns on potential biases which threats the credibility of the results (More details are given in the attached file).
-In some cases, there are no significant association between exposure and outcome, but less attention was given to these (e.g., the possibility of limitation of questionnaire in capturing the HRQoL may resulted in non-significant association between one CVD and HRQoL).
REPORTING & ETHICS
-As I said above, there are some items which are not presented very well at the manuscript.
-I can not evaluate the publication ethics.
GENERAL COMMENTS
Djärv et al. investigated the impact of cardiovascular diseases on the health related quality of life (HRQoL) among a large sample size of general population in Sweden. This is an interesting topic, especially from a health economics perspective; these types of studies are very helpful for developing the economic models as they prevent the need for populating the impact of different CVD events from different studies which may increase the uncertainty in the models. The article is generally well written. However, there are some concerns on the validity of the results which should be considered in the reporting of the results. I give my comments separately for each section. Abstract Introduction 1. In the introduction and also in discussion sections of the manuscript, authors stated that their study is the first study of its type. However, as I know, at least there is one previous study which examined the impact of cardiovascular diseases on HRQoL in general population. I think this article should be used as a reference in the current study and the statements such as none previous study or first study should be avoided. In first paragraph of page 6, it was said that a questionnaire was sent to eligible individuals. Does this imply that there were some eligibility criteria for participation? If so, these criteria should be mentioned in this section. 2. In second paragraph of page 6, authors said that previous stroke was considered as co-morbidity and it was excluded from cardiovascular diseases (CVD). While, stroke is one of the main components of CVD, the reason for excluding it from the definition of CVD should be given. 3. For measuring the HRQoL, a disease-specific tool (QLQ-C30) was applied. The reason for using this tool, while many validated generic tools are available, should be justified. Maybe, this study is a secondary analysis of an original study. If so, then a brief description of original study can help the readers. 4. In the statistical analysis, authors controlled for physical activity and smoking status. I guess these two variables were considered as potential confounders. However, if CVD affected the people behavior, then these variables change to mediators variables instead of confounders. With the way of defining smoking status, there is less possibility of this problem. However, for physical activity this could be case. If so, then control for this variable may raise bias in the results (Of course, if authors are interested in total effect of CVD on HRQoL). Hence, the main research question should be clarified and if total effect is main interest, then authors should describe how they deal with this potential bias (excluding physical activity from the analysis or assuming and justifying that physical activity did not affect by CVD). 5. It is believed that impact of CVD events on HRQoL is diminishing over time. So, the time of event is a significant factor which should be considered in these studies. Why it was not included in the analysis? If it is due to lack of data, then possible biases should be discusses in the discussion (e.g., if people with a long time since event are more common in the sample, then the results are not generalizable for the patients with short time since event). 6. In the statistical analysis sub-section, authors should give information on what was done for checking the potential effect modifiers (i.e., which interaction terms were checked). 7. While the data on the distribution of missing values are given in Table 1 , the nature of missingness (completely at random, at random or not at random) and method of handling them were not described (drop or impute). 8. The explanation for the sample size has not been given (based on what criteria/parameters, the 7002 people were selected in the first step). Results 1. In the first paragraph, it was said that 2001 people did not respond the questionnaire and these people were not different than participants in terms of socio-demographic characteristics. What about the clinical characteristics? Was non-response related to CVD? Reasons for non-participation should be given because if nonresponse is associated with CVD and possibly HRQoL, then the sample selection bias raised. If there is no data, then this potential bias should be discussed in the discussion. 2. It would be helpful if authors add one column to the Table 1 and give information on non-responders. Moreover, I suggest adding one row to this Table 3 and 4, generally there were no significant differences between having one CVD and poor HRQoL. Is this a true effect or it is because the applied questionnaire was not responsive enough to capture the aspects of HRQoL in general population (as I mentioned before, the questionnaire is a cancerspecific tool). This should be discussed in discussion. 5. In page 10, authors said that an increased number of CVD was associated with an increased risk of poor HRQoL on all HRQoL aspects. However, later they said that there were no significant association between number of CVD and emotional function. So, the first sentence should be corrected. Discussion 1. In second paragraph of page 12, authors considered using the EORTC QLQ-C30 as strength of the study. With my previous comments, I would not consider this as strength. 2. Authors reported that there was under-reporting of CVD among women. This raises the potential misclassification bias. This should be discussed in the discussion. 3. In the limitations of study, all potential biases which I mentioned before should be discussed. 4. In page 13, to explain the poor HRQoL among patients with CVD, authors said that it is possible that people with more CVD have more co-morbidities. This explanation is not correct, because they controlled for co-morbidity in their logistic regression. In the other word, results showed that even after control for co-morbidity, the people with more CVD had lower HRQoL in some aspects. 5. The data was self-reported by patients. So, there is possible information bias in the data which should be discussed. 6. Comparison of these results with the results of study in UK (I mentioned it before) should be added to the discussion.
7. It would be helpful if authors provide some suggestion for future research.
VERSION 1 -AUTHOR RESPONSE
Reviewer I: Jürgen Barth, Senior Researcher, Bern, Switzerland The strengths and weaknesses of the manuscript are appropriately stated by the authors. Some additional comments that require consideration:
The design of the study and the selection of patients remain unclear to me. The sentence on page 5, that participants were "matched", is confusing. Originally I was misled that this study used a case control design. But it turned out, that a cross sectional survey was conducted. Can you please specify the Design and Methods part in the paper, to make your approach more accessible for readers.
Response: Thank you for highlighting the unclear description of the design. We have now clarified the study design and selection of participants in the abstract and methods section as suggested.
The decision on how to assess QoL and how to analyse the QoL data lead to multiple implications and requires careful interpretation:
1) The scale used was originally developed for cancer patients. It remains unclear why this measure was chosen and what limitations go along with this selection. 2) The clinical interpretation of a limited QoL has been used for the definition of cut off scores. However, I would doubt that a "clinical" interpretation is established. QoL is no symptom or disorder. The underlying understanding of QoL requires clarification.
Response: Thank you for this comment. We agree that the underlying understanding of HRQoL requires clarification. Our aim of using binary cut-offs (good vs poor, no or minor symptoms vs symptomatic) is to aid the interpretation of the results in clinical practice. We have clarified our argument in the methods section and moderated our use of the words "clinical interpretation".
3) The QoL measure has a large overlap with symptoms of CHD, since it is not a generic QoL measure. This problem has neither been discussed nor does the interpretation of the findings cover this aspect.
Response: We agree with the reviewer that there is an overlap between HRQoL and objective measureable symptoms from cardiovascular disease. However, in this study we aimed to capture the effect of cardiovascular disease and the subjective burden of these on subjective ratings of HRQoL.
4)
Response: Thank you for these comments. We have now clarified the influence of the overlap between cardiovascular disease symptoms and HRQoL on the interpretation of our results. We also found it a bit surprising that emotional function was not affected, and we do not know if this is due to the questionnaire used, or because participants with depression without treatment were equally common in the group "with" as in the group "without" cardiovascular disease. Also it is possible that those with only hypertension were less likely to suffer from depression and thereby diluted the result. We have revised the discussion section.
Minor comments:
5) The presentation of the results of table 2 in the text is highly selective. Non-significant results have not been discussed.
Response: We agree with the reviewer and have added a mention of the non-significant results in the results section. Introduction 1. In the introduction and also in discussion sections of the manuscript, authors stated that their study is the first study of its type. However, as I know, at least there is one previous study which examined the impact of cardiovascular diseases on HRQoL in general population. I think this article should be used as a reference in the current study and the statements such as none previous study or first study should be avoided. The reference is: Ara R, Methods 1. In first paragraph of page 6, it was said that a questionnaire was sent to eligible individuals. Does this imply that there were some eligibility criteria for participation? If so, these criteria should be mentioned in this section.
2. In second paragraph of page 6, authors said that previous stroke was considered as co-morbidity and it was excluded from cardiovascular diseases (CVD). While, stroke is one of the main components of CVD, the reason for excluding it from the definition of CVD should be given.
Response: We did not exclude participants with previous stroke, but categorized previous stroke as a co-morbidity instead of a primary cardiovascular disease. Our main reason for this is that there is a risk that participants with a previous stroke may be more likely to report HRQoL based on the stroke than on their other cardiovascular diseases. The reason for selecting previous stroke as a co-morbidity has been added to the methods section.
3. For measuring the HRQoL, a disease-specific tool (QLQ-C30) was applied. The reason for using this tool, while many validated generic tools are available, should be justified. Maybe, this study is a secondary analysis of an original study. If so, then a brief description of original study can help the readers.
Response: The main reason for sampling the data was to create a reference database for HRQoL; this has been stated in the methods section. Further specific reasons for selecting the EORTC QLQ-C30 are presented in the responses to reviewer 1, comment 1.
4. In the statistical analysis, authors controlled for physical activity and smoking status. I guess these two variables were considered as potential confounders. However, if CVD affected the people behavior, then these variables change to mediators variables instead of confounders. With the way of defining smoking status, there is less possibility of this problem. However, for physical activity this could be case. If so, then control for this variable may raise bias in the results (Of course, if authors are interested in total effect of CVD on HRQoL). Hence, the main research question should be clarified and if total effect is main interest, then authors should describe how they deal with this potential bias (excluding physical activity from the analysis or assuming and justifying that physical activity did not affect by CVD).
Response: As the reviewer mentioned, we considered both smoking and physical activity as potential confounders for good or poor HRQoL. Since it is a cross-sectional study we cannot study causation but still control for the actual state. Also, since physical activity was assessed as frequency rather than intensity, we assume that cardiovascular diseases might limit the activity to a lesser degree.
5. It is believed that impact of CVD events on HRQoL is diminishing over time. So, the time of event is a significant factor which should be considered in these studies. Why it was not included in the analysis? If it is due to lack of data, then possible biases should be discusses in the discussion (e.g., if people with a long time since event are more common in the sample, then the results are not generalizable for the patients with short time since event).
Response: Unfortunately we lack the important information on time since the event. We have now added a discussion of this issue to the revised manuscript.
6. In the statistical analysis sub-section, authors should give information on what was done for checking the potential effect modifiers (i.e., which interaction terms were checked).
Response: All analyses were specified a priori to avoid fishing, thus no interaction terms were studied, only a full multivariable model were used as set out in our study protocol.
7. While the data on the distribution of missing values are given in Table 1 , the nature of missingness (completely at random, at random or not at random) and method of handling them were not described (drop or impute).
Response: We apologize for not including information on missing data. Missing data were dropped and no data were imputed. We have updated the manuscript to include this information.
8. The explanation for the sample size has not been given (based on what criteria/parameters, the 7002 people were selected in the first step).
Response: The original purpose of the data collection was to create a reference database for HRQoL covering a range of different aspects, such as different diseases in the general population. The number of participants was based on the expected response rate, power calculations for subgroups and previous similar population-based reference value studies. We have added further details on the eligibility criteria and sampling method to the methods section of the revised manuscript.
Results 1. In the first paragraph, it was said that 2001 people did not respond the questionnaire and these people were not different than participants in terms of socio-demographic characteristics. What about the clinical characteristics? Was non-response related to CVD? Reasons for non-participation should be given because if non-response is associated with CVD and possibly HRQoL, then the sample selection bias raised. If there is no data, then this potential bias should be discussed in the discussion.
Response: Unfortunately no other data are available for non-responders than sociodemographic characteristics. We have acknowledged this as a limitation in the discussion section of the revised manuscript.
2. It would be helpful if authors add one column to the Table 1 and give information on nonresponders. Moreover, I suggest adding one row to this Table and report the distribution of major and minor burden among participants.
Response: Thank you for this suggestion. However as we have data only on age and gender we feel that this is not suitable to present in Table 1 . Further, we believe that presenting information on burden for participants without cardiovascular disease is not in line with the aims of the study. Information on burden of cardiovascular disease is therefore presented in Table 5 .
3. In page 10, authors reported an OR 8.78 with 95% CI 1.24-62.01 for association between poor role function and atrial fibrillation. This high value and wide CI can be an indication of data problem, especially considering the low number of events relative to explanatory variables. This should be checked.
Response: Thank you for highlighting this issue. We agree with the reviewer that the OR and wide CI indicate a potential data problem, however, this is likely due to the small number of cases within this group. The numbers presented are correct, but results must be interpreted with caution. This is mentioned as a limitation in the discussion section of the revised manuscript. Table 3 and 4, generally there were no significant differences between having one CVD and poor HRQoL. Is this a true effect or it is because the applied questionnaire was not responsive enough to capture the aspects of HRQoL in general population (as I mentioned before, the questionnaire is a cancer-specific tool). This should be discussed in discussion.
Based on the results in
Response: We agree with the reviewer, it might be either a true effect, since most participants suffered from hypertension which might be a more "silent" disease than others, or due to the questionnaire. We have added this to the discussion section.
